Inzoomen: druk op uw toetsenbord op CtrlCommand + +
Uitzoomen: druk op uw toetsenbord op CtrlCommand + -
Gebruik knijpzoomen om eenvoudig in en uit te zoomen

DERMISHEAD study

Laatste wijziging: 24 januari 2022

Low-level laser therapy for the prevention and management of radiodermatitis in head and neck cancer patient

 

Principal Investigator: Prof. Dr. Jeroen Mebis, Researcher: Jolien Robijns

 

90% of the cancer patients undergoing radiotherapy are affected by radiodermatitis or  a painful inflammation of the skin as a result of radiation treatments. Current methods of treatment for radiodermatitis consist of several creams, gels and wound bandages. However, these methods are not sufficiently effective. Therefore, it is important to seek out new techniques for the treatment of radiodermatitis. A recent study by our research group shows that low-level laser therapy (LLLT) is an effective treatment for radiodermatitis in breast cancer patients.

In the current study, the use of laser therapy for the prevention and treatment of radiodermatitis in head and neck cancer patients will be further investigated. Moreover, it will be investigated whether LLLT can regulate the production of inflammatory molecules in the skin to investigate the underlying mechanism of LLLT.